AAV2/8-HLP-FVIII-V3 clinical trials

Gene Therapy for Haemophilia A.

This study is testing a new gene therapy for severe Haemophilia A. It aims to see if a one-time treatment can safely help the body make its own clotting factor, potentially reducing the need for regular injections.